The rise of antibiotic resistant bacteria: could bacteriophage be the solution?
The fight between bacteria and humans is one which will never go away, but in recent times antibiotics have been used to combat the deadly kingdom.
Antibiotics recognise bacteria as foreign cells due to differences between host and bacterial cell walls and they will either kill the bacteria or prevent the bacteria from multiplying, allowing the host’s defence to get rid of the infection before becoming overwhelmed.
Antibiotics are not only used to treat human illness but have been used for over half a century to control and treat diseases in livestock and poultry. It is thought that as much as 75% of antibiotics given to livestock pass through the body without properly being digested and are excreted into the environment. This means that even more resistant strains can develop.
The combination of these practices has been decreasing the effectiveness of antibiotics in treating common infections, generating much concern over how useful they now are.
The director general of the World Health Organisation, Dr Margaret Chan, said: “The world is heading towards a post-antibiotic era in which many common infections will no longer have a cure and, once again, kill unabated.”
In the US alone, two million people are becoming infected with bacteria that have resistance to antibiotics every year, resulting in 23,000 deaths.
It is becoming increasingly difficult to discover new antibiotics and those that are discovered, or existing ones that are modified to produce new forms, become ineffective soon after introduction, making development unprofitable. A solution to this problem is drastically needed and bacteriophage may just be the answer.
In 1896, Ernest Hanbury Hankin reported something in the water of the River Ganges in India that had antibacterial action against cholera. In 1915, Frederick Twort noticed that bacteria infecting his plates kept becoming transparent and in 1917, Felix d’Herelle discovered an invisible microbe opposing bacteria. He called the responsible agent a bacteriophage.
The bacteriophage is a virus that infects and kills bacteria – a parasite that depends on the host bacteria cell for its survival.
It hijacks the host’s biological function and uses the host machinery for reproduction. The infected bacteria cell will eventually lyse and die, releasing further phage that the parent phage has produced which can then infect neighbouring bacterial cells.
It has shown a lot of promise as a potential treatment against bacteria for a while, however research was largely abandoned in the West once antibiotics took off. Now however, due to the increasing resistance, they are cropping up as an option more and more.
This doesn’t come without criticism, but there is overwhelming evidence that phage have a future in healthcare.
In Georgia, phage are used to treat all kinds of bacterial infections at the Eliava Institute. One patient comments about his recurring eye infection, “I’ve tried everything. I’ve even had operations on my eye and nothing helped. But this does.”
The first clinical trial on the use of phage occurred in 2009, and involved targeting the antibiotic resistant Pseudomonas aeruginosa bacteria which causes chronic otitis. The trial showed efficacy and safety and a year later in an evaluation on the phage treatment for dogs with chronic otitis, the phage lead to lysis of the bacteria in the ear without any apparent toxicity.
The bacteriophage provide certain advantages over antibiotics.
First of all, the ability of phage to specifically recognise their host targets means that they can kill the target bacteria without harming the beneficial bacteria in the organism, so that potential side effects of antibiotics can be avoided.
Bacteriophage, unlike antibiotics, can mutate and evolve in parallel to bacteria mutation, largely countering phage resistant bacteria – according to some microbiologists, bacterial resistance to phage will develop at a rate tenfold lower than that to antibiotics.
Although there is no evidence that exposure to bacteriophage results in human disease, there may be negative interactions with the immune system as some phage preparations have been found to stimulate unwanted immune system activity.
Also, although they can be shown to work in vitro in the lab, the results may not be as replicable in whole living organisms and in certain individuals.
Antibiotic resistance is beginning to cause huge problems for the healthcare industry. A solution is much needed, and bacteriophage have shown effectiveness in clinical trials. However, further research must be done on their effect on the immune system to make sure that they are safe before they can be used as a routine treatment.
Photograph: AJC1 on flickr

